Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Icy Hot is a prominent American brand of topical pain relief products, recognized for its signature dual-action sensation of cooling to dull pain followed by warming to relax it. The brand's portfolio includes a wide range of over-the-counter formulations such as medicated patches, creams, sprays, balms, and rollers. These products utilize active ingredients like menthol, methyl salicylate, and lidocaine to provide temporary relief from minor aches and pains associated with arthritis, backache, and muscle strains. Originally a flagship brand of Chattem, it became a key asset in Sanofi's consumer healthcare division following the acquisition of Chattem in 2010. Icy Hot continues to lead the topical analgesic market through continuous product innovation, including the introduction of the Icy Hot Pro line and lidocaine-infused variants.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Icy Hot.